Speakers

  • Itamar Raz, Israel | Congress Chairperson

    Itamar Raz, Israel | Congress Chairperson

    Itamar Raz, MD, received his medical degree from the Hadassah Hebrew University Medical School in Jerusalem in 1980. He is board certified in Internal Medicine, is a full professor of Internal Medicine and was the Head of the Diabetes Unit at Hadassah University Hospital 2000-2015...
    Read More..
  • Amanda Adler, UK

    Amanda Adler, UK

    Dr Adler is a Consultant Physician at Addenbrooke's Hospital, Cambridge, and Chair of Technology Appraisal Committee B at the National Institute for Health and Care Excellence (NICE).  
    Read More..
  • Antonio Ceriello, Spain

    Antonio Ceriello, Spain

    After earning his medical degree and specialty degree in diabetology and metabolic diseases at the University of Naples, Prof. Antonio Ceriello went on to hold a number of important research and professorship positions at prestigious scientific and academic institutions located in continental Europe, the U.S. and the U.K., ...
    Read More..
  • Stefano Del Prato, Italy |Organizing Committee

    Stefano Del Prato, Italy |Organizing Committee

    Dr Del Prato is Professor of Endocrinology and Metabolism at the School of Medicine, University of Pisa and Chief of the Section of Diabetes, University of Pisa, Italy. He graduated MD cum laude from the University of Padova and undertook post-graduate specialization in both Endocrinology and Internal Medicine
    Read More..
  • Roy Eldor, USA

    Roy Eldor, USA

    Roy Eldor is an endocrinologist, internist and researcher with over twenty years of clinical and scientific experience. He is a recognized expert, with over 35 peer reviewed papers and book chapters and an invited  speaker  in  international  meetings.
    Read More..
  • Alexander Fleming, USA

    Alexander Fleming, USA

    Dr. Alexander Fleming received his M.D. and internal medicine training from Emory, fellowship training in endocrinology at Vanderbilt and metabolism at National Institutes of Health, where he was a senior fellow. 
    Read More..
  • Helen Gao, USA

    Helen Gao, USA

    Helen Gao is a Senior Associate with Close Concerns, a diabetes and obesity information company based in San Francisco.
    Read More..
  • Thomas Forst, Germany

    Thomas Forst, Germany

    March 2015 – until now
    Director Medical Sciences, Profil Institut für Stoffwechsel-forschung, Neuss

    March, 2013 - February 2015
    Chief Executive Operatator Profil Mainz GmbH, Mainz
    Read More..
  • Ingrid Gause-Nilsson, Sweden

    Ingrid Gause-Nilsson, Sweden

    Dr. Ingrid Gause-Nilsson is Senior Medical Lead at AstraZeneca R&D, Global Medicine Development, Gothenburg, Sweden.
    Read More..
  • Anselm Gitt, Germany

    Anselm Gitt, Germany

    Biography available soon.
    Read More..
  • Markolf Hanefeld, Germany

    Markolf Hanefeld, Germany

    Markolf Hanefeld, MD, Dr. hc. PhD is Professor of Internal Medicine, Endocrinology and Diabetology. 
    Read More..
  • Robert J. Heine, USA

    Robert J. Heine, USA

    Robert J. Heine joined Lilly Diabetes in January of 2008.  He was the Vice President Global Medical Affairs for Lilly Diabetes until 2014.
    Read More...
  • Philip Home, UK | Organizing Committee

    Philip Home, UK | Organizing Committee

    Philip Home trained in medicine at Oxford University and Guy's Hospital, coming under the influence of Harry Keen, and thus gravitating into diabetes research. Continuing this research career in Newcastle upon Tyne, initially under the guidance of George Alberti, he has published over 390 papers ...
    Read More..
  • Hiddo Lambers Heerspink, Netherlands

    Hiddo Lambers Heerspink, Netherlands

    Doctor Hiddo Lambers Heerspink is affiliated with the Department of Clinical Pharmacy and Pharmacology of the University Medical Center Groningen, the Netherlands.
    Read More..
  • John M. Lachin, USA

    John M. Lachin, USA

    John Lachin is Research Professor of Biostatistics and Epidemiology at the Biostatistics Center of the George Washington University. 
    Read More...
  • Eran Leitersdorf, Israel

    Eran Leitersdorf, Israel

    Prof. Eran Leitersdorf is a graduate of the Hebrew University-Hadassah Medical School in Jerusalem. He trained in Internal Medicine, Lipid Metabolism and Molecular Genetics at the Hadassah Hebrew University Medical Center, at the laboratory of MS Brown and JL Goldstein of the Southwestern Medical Center in Dallas and at the laboratory of JC Fruchart of the Pasteur Institute in Lille, France. 
    Read More...
  • John New, UK

    John New, UK

    Professor John New is a Consultant Diabetologist at Salford Royal Foundation Trust, the Chief Clinical Officer for NorthWest EHealth (NWEH) and the NWEH Clinical Director of the Salford Lung Study (SLS). He is also an Honorary Lecturer at the University of Manchester.
    Read More...
  • James Nolan, USA

    James Nolan, USA

    Mr. Nolan has more than 25 years of experience in the life sciences industry, representing numerous major pharmaceutical companies
    Read More..
  • Ran Oren, Israel

    Ran Oren, Israel

    Ran Oren is Professor of Gastroenterology & Hepatology at the Faculty of Medicine, the Hebrew University and he is the Head of the Institute of Gastroenterology and Liver Disease at Hadassah Ein Karem Hospital , Jerusalem, Israel
    Read More...
  • Paolo Pozzilli, Italy

    Paolo Pozzilli, Italy

    Paolo Pozzilli has received his Degree in Medicine and specialized in Endocrinology & Metabolic Diseases from University “Sapienza” of Rome, Italy. Since then he has worked mainly in the field of diabetes with particular focus into type 1 diabetes (T1D) pathogenesis and prevention in collaboration with several investigators around the world for more than 30 years. 
    Read More..
  • Andreas Pfützner, Germany

    Andreas Pfützner, Germany

    Prof. Andreas Pfützner is Managing Director of the Pfützner Science & Health Institute, Diabetes Center & Practice in Mainz, Germany, focussing on insulin and insulin analogues, diabetes technology and medical device development. 
    Read More...
  • Giuseppe M.C. Rosano, Italy

    Giuseppe M.C. Rosano, Italy

    After obtaining his MD in Medicine and Surgery, at the La Sapienza University of Rome with full honors in 1988, Giuseppe Rosano, obtained his specialisation in Cardiology in 1992, before attaining his PhD in Medical Sciences from the Imperial College in London. 
    Read More..
  • Oliver Schnell, Germany | Organizing Committee

    Oliver Schnell, Germany | Organizing Committee

    Oliver Schnell is a Professor at the Ludwig-Maximilians-University in Munich and at the Forschergruppe Diabetes e.V. Munich. 
    Read More..
  • Eberhard Standl, Germany

    Eberhard Standl, Germany

    Dr. Eberhard Standl is a Professor of Medicine, specializing in endocrinology and angiology, at the Munich Diabetes Research Group e.V. at Helmholtz Centre. Dr. Standl's principal areas of research include diabetology, action and degradation of insulin and epidemiology of cardiovascular diabetic complications.
    Read More..
  • Gayle van Krevelen, The Netherlands

    Gayle van Krevelen, The Netherlands

    Over 10 years’ experience in clinical trials as Clinical Research Associate, CRA Manager and Trainer.
    Read More..
  • Manu Venkat, USA

    Manu Venkat, USA

    Manu Venkat was an Associate at Close Concerns from 2013 through 2015, reporting primarily on diabetes drug therapies. 
    Read More..
  • Maximilian von Eynatten, Canada

    Maximilian von Eynatten, Canada

    Maximilian von Eynatten is a board certified nephrologist with additional specialization in diabetes (DDG). 
    Read More...